Iria Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Iria Silva has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Abdellaziz Dahou
Division of Cardiovascular Imaging, St. Francis Hospital and Heart Center, Catholic Health
1 shared publication- Alberto Alperi
Cardiology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
1 shared publication - Alexis Theron
Service de chirurgie cardiaque, Hôpital de la Timone , Marseille 13385
1 shared publication - Antonela Zanuttini
Laval University
1 shared publication Benjamin Camacho
Hospital Arnau de Vilanova
1 shared publication- Carlos Giuliani
Department of Cardiology, Quebec Heart & Lung Institute – Laval University, Canada (C.G., A.Z., P.P.).
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e047196
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women With Severe Aortic Stenosis: The RHEIA Trial
Background: In the RHEIA (Randomized Research in Women All Comers With Aortic Stenosis) trial, the incidence of the primary end point of death, stroke, or rehospitalization at 1 year was lower with transcatheter aortic valve implantation (TAVI) than with surgical aortic valve replacement. The objective of this substudy was to compare echocardiographic findings in women with severe aortic stenosis following surgical aortic valve replacement or TAVI. Methods: At 48 European centers, 443 women underwent randomization 1:1, and 420 were treated as randomized. Echocardiograms were available in 356 patients and were analyzed by a core laboratory. Results: Rates of or greater moderate paravalvular regurgitation was low (P =1) was low and not different between groups. Valve hemodynamics were stable at 1 year. The rate of residual left ventricular hypertrophy (45.3 versus 28.6%; P =0.004) at 1 year was significantly higher with TAVI, whereas the rate of right ventricular systolic dysfunction (14.5 versus 40.7%; P P =0.001) were better with TAVI. Conclusions: Among women with severe aortic stenosis, both TAVI and surgical aortic valve replacement achieve excellent valve hemodynamic results with low and similar rates of moderate or greater paravalvular regurgitation or severe patient–prosthesis mismatch. Surgical aortic valve replacement was associated with lower gradients and more pronounced regression of left ventricular hypertrophy, whereas TAVI was associated with better right ventricular systolic function and evolution of cardiac damage stage. REGISTRATION: URL: https://clinicaltrials.gov/study/NCT04160130 ; Unique Identifier: NCT04160130.
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e047196
Open AccessEchocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Women With Severe Aortic Stenosis: The RHEIA Trial
Background: In the RHEIA (Randomized Research in Women All Comers With Aortic Stenosis) trial, the incidence of the primary end point of death, stroke, or rehospitalization at 1 year was lower with transcatheter aortic valve implantation (TAVI) than with surgical aortic valve replacement. The objective of this substudy was to compare echocardiographic findings in women with severe aortic stenosis following surgical aortic valve replacement or TAVI. Methods: At 48 European centers, 443 women underwent randomization 1:1, and 420 were treated as randomized. Echocardiograms were available in 356 patients and were analyzed by a core laboratory. Results: Rates of or greater moderate paravalvular regurgitation was low (P =1) was low and not different between groups. Valve hemodynamics were stable at 1 year. The rate of residual left ventricular hypertrophy (45.3 versus 28.6%; P =0.004) at 1 year was significantly higher with TAVI, whereas the rate of right ventricular systolic dysfunction (14.5 versus 40.7%; P P =0.001) were better with TAVI. Conclusions: Among women with severe aortic stenosis, both TAVI and surgical aortic valve replacement achieve excellent valve hemodynamic results with low and similar rates of moderate or greater paravalvular regurgitation or severe patient–prosthesis mismatch. Surgical aortic valve replacement was associated with lower gradients and more pronounced regression of left ventricular hypertrophy, whereas TAVI was associated with better right ventricular systolic function and evolution of cardiac damage stage. REGISTRATION: URL: https://clinicaltrials.gov/study/NCT04160130 ; Unique Identifier: NCT04160130.